Centene Corporation logo CNC - Centene Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 27
HOLD 15
SELL 1
STRONG
SELL
0
| PRICE TARGET: $56.67 DETAILS
HIGH: $80.00
LOW: $39.00
MEDIAN: $58.50
CONSENSUS: $56.67
DOWNSIDE: 4.18%

Stock News

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

Here Are Wednesday’s Top Wall Street Analyst Research Calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation may as well. All of the major indices finished Tuesday lower, and with Q1 earnings all but over and the incoming economic data... Here Are Wednesday's Top Wall Street Analyst Research Calls: BJ's Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and More

May 20, 2026 03:59 AM 247wallst.com
Centene: Further Upside Will Require Better Execution

Centene: Further Upside Will Require Better Execution

Centene rebounded in Q1-2026 with a significant improvement in its health benefits ratio, dropping to 87.3% from 94.3% in Q4-2025. CNC's Medicaid HBR improvement was driven by rate increases, medical cost management, and a mild flu season, though management remains cautious on sustainability. Despite a strong Q1-2026 beat, CNC raised full-year guidance less than the quarterly outperformance, reflecting uncertainty about trend continuation.

May 01, 2026 11:47 AM seekingalpha.com
CENTENE CORPORATION REPORTS FIRST QUARTER 2026 RESULTS

CENTENE CORPORATION REPORTS FIRST QUARTER 2026 RESULTS

-- First Quarter GAAP Diluted Earnings Per Share of $3.11; Adjusted Diluted Earnings Per Share of $3.37 -- -- Increases 2026 GAAP Diluted EPS Guidance to Greater than $2.37 & Adjusted Diluted EPS to Greater than $3.40 -- Strong first quarter 2026 adjusted diluted EPS of $3.37, approximately $0.50 better than our expectations. Medicaid HBR of 93.1%, reflecting continued tangible progress managing medical costs coupled with moderate flu.

Apr 28, 2026 02:00 AM prnewswire.com

Price Targets